Contract Research Organization (CRO) Services Market

Contract Research Organization (CRO) Services Market (Service Type: Early Phase Development [Discovery Services, Chemistry, and Preclinical Services], Clinical Research Services [Phase I, Phase II, Phase III, and Phase IV], Laboratory Services [Bioanalytical Services, Analytical Services, and Others], and Consulting Services; Therapeutic Indication: Oncology, Infectious Diseases, Immunological Disorders, Respiratory Diseases, Cardiovascular Diseases, Neurological Disorders, and Others; and End User: Medical Device Companies, Biopharmaceutical Companies, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Rise in Number of Drug Development Projects to Propel Demand for CRO Services

CRO services have gradually penetrated the healthcare sector in the past few years. With significant developments in the healthcare sector in terms of research, medications, drug delivery, etc., CROs are increasingly gaining prominence. As healthcare providers continue to recognize the benefits and advantages of consulting and opting for CRO services, the demand for such services is expected to grow at a significant pace during the forecast period (2019-2027). In the past few years, instead of outsourcing the entire project, biotech companies are leaning toward outsourcing part of clinical trials to CROs. In addition, stakeholders in the current contract research organization (CRO) services market are focusing their attention toward catering to niche and customized requirements of clinical trials.

In recent times, CRO services are assisting companies in the early phase development of new drugs and medications. Clinical research, consulting, and laboratory CRO services are increasingly being used by pharmaceutical companies, a factor expected to propel the growth of the contract research organization (CRO) services market during the assessment period. In addition, stakeholders involved in the current contract research organization (CRO) services market are expected to collaborate with each other to formulate open technology standards that are likely to revolutionize the future of clinical trial operations. Due to these factors and positive outlook of the healthcare sector, the global contract research organization (CRO) services market is expected to reach a value of ~US$ 96.4 Bn by 2027.

contract research organizations services market infographic

To know the scope of our report Get a Sample on Contract Research Organization (CRO) Services Market   

Focus on R&D in Pharmaceuticals Offers Growth Opportunities for Stakeholders

In the past decade, research and development in the pharmaceutical sector has experienced considerable increase. Established companies in the pharmaceutical sector are leaning toward leaner business models wherein dependence on external entities, such as CROs, is high. The significant growth of the biotech sector in the past decade has played an important role in resulting in rise in the number of companies involved in research and drug development. The exponential rise in the number of active and upcoming drug development companies and research projects created a huge window of opportunity for stakeholders involved in the contract research organization (CRO) services market. In the past decade, outsourcing of large or complex aspects of the drug development process has become imperative for the development of new drugs effectively and cost-effectively.

Get a glimpse of the in-depth analysis through our Report Brochure

Although drug developers are increasingly leveraging CROs services, they are continually seeking solutions to address a host of challenges involved with this approach, such as high R&D cost, obtaining access and tracking the operations that are outsourced, and capacity constraints, among others. At present, stakeholders in the contract research organization (CRO) services market are increasingly adapting to the evolving research & development requirements and are expected to manage contracted work in several modalities. The number of outsourced projects in the last decade has transformed the overall structure of the drug development industry.

Adoption of CROs Services to Accelerate Early Phase Drug Development

The lack of horizontal integration in the contract research organization (CRO) services market has largely been responsible for the inefficiencies in the operations and workflows. Furthermore, this has also isolated drug development processes, which has thus, encouraged the formulation of integrated CRO services models. The growing adoption of integrated model across the pharmaceutical sector has played an integral role in improving efficiency and minimizing the make-test cycle. While the horizontal integration model offered significant benefits and efficiencies in the drug development phase, its adoption in the U.S. was relatively slower than European countries such as the U.K. The demand for CROs services for early phase drug development and clinical research is expected to grow in the coming decade, due to a range of factors, including improved efficiency, streamlined management of R&D costs, low risk of repeat studies, accelerated drug development, and lowered operational costs, among others. Apart from offering monetary benefits, integrated contract organization services are likely to simply the supply chain and efficient management of clinical data.

contract research organizations services market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report 

Analysts’ Viewpoint

The global contract research organization (CRO) services market is expected to grow at an impressive CAGR of ~8% during the forecast period. The growth of the market can be largely attributed to significant rise in the number of drug development projects across the globe. Moreover, biotech and pharmaceutical companies are increasingly relying on CRO services to complete certain steps of the clinical development of drugs, which will create significant demand for CRO services during the forecast period. The outlook for the contract research organization (CRO) services market during the forecast period is positive, owing to the advent of integrated CRO models. Additionally, Stakeholders in the contract research organization (CRO) services market should focus on collaborating with pharmaceutical companies and leverage opportunities in North America and Europe– the two prominent regions in which large-scale drug development projects are being initiated.

Contract Research Organization (CRO) Services Market: Overview

  • The global contract research organization (CRO) Services market was valued at ~US$ 49 Bn in 2018 and is projected to expand at a high CAGR from 2019 to 2027. The global market is driven by increased spending on research and development by manufacturers, patent expiries of various biologics leading to increase in the number of clinical trials, rising penetration of CROs, and growing focus of market players on conducting clinical trials in emerging markets.
  • Contract research organizations (CROs) are engaged in offering a range of research services on a contract basis to pharmaceutical, medical device, and biotechnology companies
  • Large biopharmaceutical companies have been outsourcing most of their research and development activities in order to shift from fixed costs to variable costs, increase their access to new technological capabilities, and expand their global reach. This is promoting growth of the global contract research organization (CRO) services market.
  • Rising prevalence of cancer globally is a key factor driving the number of clinical trials being conducted. Furthermore, the global number of clinical trials in oncology increased from over 2,400 in 2007 to over 7,000 in 2017. 

Contract Research Organization (CRO) Services: Market Segmentation

  • The global contract research organization (CRO) services market has been segmented based on service type, therapeutic indication, end user, and region
  • In terms of service type, the global contract research organization (CRO) services market has been categorized into early phase development, clinical research services, laboratory services, and consulting services. The early phase development segment has been sub-segmented into discovery services, chemistry, and preclinical services. The preclinical services sub-segment has been further divided into toxicology, pharmacokinetics, and others. The clinical research services segment has been sub-classified into phase I, phase II, phase III, and phase IV. The laboratory services segment has been sub-categorized into bioanalytical services, analytical services, and others.
  • Based on therapeutic indication, the global contract research organization (CRO) services market has been segregated into oncology, infectious diseases, immunological diseases, respiratory diseases, cardiovascular diseases, neurological disorders, and others
  • Based on end user, the global contract research organization (CRO) services market has been divided into medical device companies, biopharmaceutical companies, and others 

Contract Research Organization (CRO) Services Market: Regional Segmentation

  • In terms of region, the global contract research organization (CRO) services market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • North America dominated the global contract research organization (CRO) services market in 2018 and the trend is expected to continue throughout the forecast period
  • The contract research organization (CRO) services market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period. Japan is one of the largest industries for clinical trials in Asia Pacific and it witnesses significant product registrations. Large-sized CROs operating worldwide are focused on expanding their presence in Japan through investments in facilities and resources in functional services such as central laboratories, imaging, and clinical supplies. 

Contract Research Organization (CRO) Services Market: Major Players

  • Key players operating in the global contract research organization (CRO) services market are
    • Laboratory Corporation of America Holdings
    • IQVIA Inc.
    • Syneos Health, Inc.
    • Parexel International Corporation
    • PRA Health Sciences, Inc.
    • PPD, Inc.
    • Charles River Laboratories, Inc.
    • Icon plc
    • WuXi AppTec Group
    • Medpace
  • These players are focused on adopting inorganic growth strategies to strengthen their product portfolio. These companies have adopted strategies such as partnerships and acquisitions to strengthen their market position, expand their portfolio of services, and expand their geographical presence. 

Contract Research Organization (CRO) Services Market – Segmentation

Service Type

Early Phase Development

  • Discovery Services
  • Chemistry
  • Preclinical Services
    • Toxicology
    • Pharmacokinetics
    • Others

Clinical Research Services

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Laboratory Services

  • Bioanalytical Services
  • Analytical Services
  • Others

Consulting Services

Therapeutic Indication

Oncology

Infectious Diseases

Immunological Disorders

Respiratory Diseases

Cardiovascular Diseases

Neurological Disorders

Others

End User

Medical Device Companies

Biopharmaceutical Companies

Others

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

What is the total market worth of contract research organization (CRO) services market?

Contract research organization (CRO) services market is expected to reach a value of ~US$ 96.4 Bn by 2027

What is the anticipated CAGR of the contract research organization (CRO) services market in the forecast period?

Contract research organization (CRO) services market is projected to expand at a high CAGR of 8% during 2019 - 2027

What are the key driving factors for the growth of the contract research organization (CRO) services market?

Contract research organization (CRO) services market is driven by increase in the penetration of CROs, globalization of clinical trials

Which region is expected to project the highest market share in the global contract research organization (CRO) services market?

North America accounted for a major share of the global contract research organization (CRO) services market and the trend is anticipated to continue during the forecast period

Who are the key players in the global contract research organization (CRO) services market?

Key players operating in the global contract research organization (CRO) services market are Laboratory Corporation of America Holdings, IQVIA Inc., Syneos Health, Inc., Parexel International Corporation, PRA Health Sciences

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Acronyms

    3. Research Methodology

    4. Executive Summary: Global Contract Research Organization (CRO) Services Market

    5. Market Overview

        5.1. Definition

        5.2. Market Indicators

        5.3. Market Dynamics

            5.3.1. Drivers

            5.3.2. Restraints

            5.3.3. Opportunities

    6. Market Outlook

        6.1. Global Contract Research Organization (CRO) Services Market Revenue (US$ Mn) Forecast 2017–2027

        6.2. Global Contract Research Organization (CRO) Services Market Outlook

        6.3. Regulatory Scenario, by Region/Global

        6.4. Clinical Trials Analysis

        6.5. Key Mergers and Acquisitions

        6.6. Heat Map Analysis

        6.7. CROs - Business Model

        6.8. CROs - Pricing Strategies

    7. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Service Type 

        7.1. Introduction 

        7.2. Global CRO Services Market Value Share Analysis, by Service Type

        7.3. Global CRO Services Market Value Forecast, by Service Type, 2017–2027

            7.3.1. Early Phase Development 

                7.3.1.1. Discovery Services

                7.3.1.2. Chemistry

                7.3.1.3. Preclinical Services 

                    7.3.1.3.1. Toxicology

                    7.3.1.3.2. Pharmacokinetics 

                    7.3.1.3.3. Others

            7.3.2. Clinical Research Services

                7.3.2.1. Phase I

                7.3.2.2. Phase II

                7.3.2.3. Phase III

                7.3.2.4. Phase IV

            7.3.3. Laboratory Services 

                7.3.3.1. Bioanalytical Services 

                7.3.3.2. Analytical Services 

                7.3.3.3. Others

            7.3.4. Consulting Services 

        7.4. Global CRO Services Market Attractiveness, by Service Type 

    8. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Therapeutic Indication 

        8.1. Introduction 

        8.2. Global CRO Services Market Value Share Analysis, by Therapeutic Indication

        8.3. Global CRO Services Market Value Forecast, by Therapeutic Indication, 2017–2027

            8.3.1. Oncology

            8.3.2. Infectious Diseases

            8.3.3. Immunological Disorders

            8.3.4. Respiratory Diseases

            8.3.5. Cardiovascular Diseases

            8.3.6. Neurological Disorders

            8.3.7. Others

        8.4. Global CRO Services Market Attractiveness, by Therapeutic Indication

    9. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by End-user 

        9.1. Introduction 

        9.2. Global CRO Services Market Value Share Analysis, by End-user

        9.3. Global CRO Services Market Value Forecast, by End-user, 2017–2027

            9.3.1. Medical Device Companies 

            9.3.2. Biopharmaceutical Companies 

            9.3.3. Others

        9.4.  Global CRO Services Market Attractiveness, by End-user

    10. Global Contract Research Organization (CRO) Services Market Analysis and Forecast, by Region 

        10.1. Regional Outlook

        10.2. Global Scenario

        10.3. Introduction

        10.4. Global Contract Research Organization (CRO) Services Market Value Forecast, by Region

            10.4.1. North America

            10.4.2. Europe 

            10.4.3. Asia Pacific

            10.4.4. Latin America 

            10.4.5. Middle East & Africa

        10.5. Global CRO Services Market Attractiveness, by Region

    11. North America Contract Research Organization (CRO) Services Market Analysis and Forecast

        11.1.  Key Findings

        11.2.  North America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

            11.2.1. Early Phase Development 

                11.2.1.1. Discovery Services

                11.2.1.2. Chemistry

                11.2.1.3. Preclinical Services 

                    11.2.1.3.1. Toxicology

                    11.2.1.3.2. Pharmacokinetics 

                    11.2.1.3.3. Others

            11.2.2. Clinical Research Services

                11.2.2.1. Phase I

                11.2.2.2. Phase II

                11.2.2.3. Phase III

                11.2.2.4. Phase IV

            11.2.3. Laboratory Services 

                11.2.3.1. Bioanalytical Services 

                11.2.3.2. Analytical Services 

                11.2.3.3. Others

            11.2.4. Consulting Services 

        11.3. North America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

            11.3.1. Oncology

            11.3.2. Infectious Diseases

            11.3.3. Immunological Disorders

            11.3.4. Respiratory Diseases

            11.3.5. Cardiovascular Diseases

            11.3.6. Neurological Disorders

            11.3.7. Others

        11.4. North America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

            11.4.1. Medical Device Companies 

            11.4.2. Biopharmaceutical Companies 

            11.4.3. Others

        11.5. North America Contract Research Organization (CRO) Services Market Value Forecast, by Country, 2017–2027

            11.5.1. U.S.

            11.5.2. Canada

        11.6. North America Contract Research Organization (CRO) Services Market Attractiveness Analysis

            11.6.1. By Service Type

            11.6.2. By Therapeutic Indication

            11.6.3. By End-user

            11.6.4. By Country

    12. Europe Contract Research Organization (CRO) Services Market Analysis and Forecast

        12.1.  Key Findings

        12.2.  Europe Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

            12.2.1. Early Phase Development 

                12.2.1.1. Discovery Services

                12.2.1.2. Chemistry

                12.2.1.3. Preclinical Services 

                    12.2.1.3.1. Toxicology

                    12.2.1.3.2. Pharmacokinetics 

                    12.2.1.3.3. Others

            12.2.2. Clinical Research Services

                12.2.2.1. Phase I

                12.2.2.2. Phase II

                12.2.2.3. Phase III

                12.2.2.4. Phase IV

            12.2.3. Laboratory Services 

                12.2.3.1. Bioanalytical Services 

                12.2.3.2. Analytical Services 

                12.2.3.3. Others

            12.2.4. Consulting Services 

        12.3. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

            12.3.1. Oncology

            12.3.2. Infectious Diseases

            12.3.3. Immunological Disorders

            12.3.4. Respiratory Diseases

            12.3.5. Cardiovascular Diseases

            12.3.6. Neurological Disorders

            12.3.7. Others

        12.4. Europe Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

            12.4.1. Medical Device Companies 

            12.4.2. Biopharmaceutical Companies 

            12.4.3. Others

        12.5. Europe Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

            12.5.1. U.K.

            12.5.2. Germany

            12.5.3. France

            12.5.4. Italy 

            12.5.5. Spain

            12.5.6. Rest of Europe

        12.6. Europe Contract Research Organization (CRO) Services Market Attractiveness Analysis

            12.6.1. By Service Type

            12.6.2. By Therapeutic Indication

            12.6.3. By End-user

            12.6.4. By Country/Sub-region

    13. Asia Pacific Contract Research Organization (CRO) Services Market Analysis and Forecast

        13.1.  Key Findings

        13.2.  Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

            13.2.1. Early Phase Development 

                13.2.1.1. Discovery Services

                13.2.1.2. Chemistry

                13.2.1.3. Preclinical Services 

                    13.2.1.3.1. Toxicology

                    13.2.1.3.2. Pharmacokinetics 

                    13.2.1.3.3. Others

            13.2.2. Clinical Research Services

                13.2.2.1. Phase I

                13.2.2.2. Phase II

                13.2.2.3. Phase III

                13.2.2.4. Phase IV

            13.2.3. Laboratory Services 

                13.2.3.1. Bioanalytical Services 

                13.2.3.2. Analytical Services 

                13.2.3.3. Others

            13.2.4. Consulting Services 

        13.3. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

            13.3.1. Oncology

            13.3.2. Infectious Diseases

            13.3.3. Immunological Disorders

            13.3.4. Respiratory Diseases

            13.3.5. Cardiovascular Diseases

            13.3.6. Neurological Disorders

            13.3.7. Others

        13.4. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

            13.4.1. Medical Device Companies 

            13.4.2. Biopharmaceutical Companies 

            13.4.3. Others

        13.5. Asia Pacific Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

            13.5.1. China

            13.5.2. India

            13.5.3. Japan

            13.5.4. Australia & New Zealand 

            13.5.5. Rest of Asia Pacific 

        13.6. Asia Pacific Contract Research Organization (CRO) Services Market Attractiveness Analysis

            13.6.1. By Service Type

            13.6.2. By Therapeutic Indication

            13.6.3. By End-user

            13.6.4. By Country/Sub-region

    14. Latin America Contract Research Organization (CRO) Services Market Analysis and Forecast

        14.1.  Key Findings

        14.2.  Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

            14.2.1. Early Phase Development 

                14.2.1.1. Discovery Services

                14.2.1.2. Chemistry

                14.2.1.3. Preclinical Services 

                    14.2.1.3.1. Toxicology

                    14.2.1.3.2. Pharmacokinetics 

                    14.2.1.3.3. Others

            14.2.2. Clinical Research Services

                14.2.2.1. Phase I

                14.2.2.2. Phase II

                14.2.2.3. Phase III

                14.2.2.4. Phase IV

            14.2.3. Laboratory Services 

                14.2.3.1. Bioanalytical Services 

                14.2.3.2. Analytical Services 

                14.2.3.3. Others

            14.2.4. Consulting Services 

        14.3. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

            14.3.1. Oncology

            14.3.2. Infectious Diseases

            14.3.3. Immunological Disorders

            14.3.4. Respiratory Diseases

            14.3.5. Cardiovascular Diseases

            14.3.6. Neurological Disorders

            14.3.7. Others

        14.4. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

            14.4.1. Medical Device Companies 

            14.4.2. Biopharmaceutical Companies 

            14.4.3. Others

        14.5. Latin America Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

            14.5.1. Brazil

            14.5.2. Mexico

            14.5.3. Rest of Latin America 

        14.6. Latin America Contract Research Organization (CRO) Services Market Attractiveness Analysis

            14.6.1. By Service

            14.6.2. By Therapeutic Indication

            14.6.3. By End-user

            14.6.4. By Country/Sub-region

    15. Middle East & Africa Contract Research Organization (CRO) Services Market Analysis and Forecast

        15.1.  Key Findings

        15.2.  Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Service Type, 2017–2027

            15.2.1. Early Phase Development 

                15.2.1.1. Discovery Services

                15.2.1.2. Chemistry

                15.2.1.3. Preclinical Services 

                    15.2.1.3.1. Toxicology

                    15.2.1.3.2. Pharmacokinetics 

                    15.2.1.3.3. Others

            15.2.2. Clinical Research Services

                15.2.2.1. Phase I

                15.2.2.2. Phase II

                15.2.2.3. Phase III

                15.2.2.4. Phase IV

            15.2.3. Laboratory Services 

                15.2.3.1. Bioanalytical Services 

                15.2.3.2. Analytical Services 

                15.2.3.3. Others

            15.2.4. Consulting Services 

        15.3. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Therapeutic Indication, 2017–2027

            15.3.1. Oncology

            15.3.2. Infectious Diseases

            15.3.3. Immunological Disorders

            15.3.4. Respiratory Diseases

            15.3.5. Cardiovascular Diseases

            15.3.6. Neurological Disorders

            15.3.7. Others

        15.4. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by End-user, 2017–2027

            15.4.1. Medical Device Companies 

            15.4.2. Biopharmaceutical Companies 

            15.4.3. Others

        15.5. Middle East & Africa Contract Research Organization (CRO) Services Market Value Forecast, by Country/Sub-region, 2017–2027

            15.5.1. GCC 

            15.5.2. South Africa

            15.5.3. Rest of Middle East & Africa 

        15.6. Middle East & Africa Contract Research Organization (CRO) Services Market Attractiveness Analysis

            15.6.1. By Service

            15.6.2. By Therapeutic Indication

            15.6.3. By End-user

            15.6.4. By Country/Sub-region

    16. Competition Landscape

        16.1.  Competition Matrix 

        16.2. Global CRO Services Market Share Analysis, by Company, 2018

        16.3.  Company Profiles

            16.3.1. Laboratory Corporation of America Holdings  

                16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.1.2. Financial Overview

                16.3.1.3. Product Portfolio

                16.3.1.4. Strategic Overview

                16.3.1.5. SWOT Analysis

            16.3.2. IQVIA Inc. 

                16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.2.2. Financial Overview

                16.3.2.3. Product Portfolio

                16.3.2.4. Strategic Overview

                16.3.2.5. SWOT Analysis

            16.3.3. Syneos Health, Inc.

                16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.3.2. Financial Overview

                16.3.3.3. Product Portfolio

                16.3.3.4. Strategic Overview

                16.3.3.5. SWOT Analysis

            16.3.4. Parexel International Corporation

                16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.4.2. Financial Overview

                16.3.4.3. Product Portfolio

                16.3.4.4. Strategic Overview

                16.3.4.5. SWOT Analysis

            16.3.5. PRA Health Sciences, Inc.

                16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.5.2. Financial Overview

                16.3.5.3. Product Portfolio

                16.3.5.4. Strategic Overview

                16.3.5.5. SWOT Analysis

            16.3.6. PPD, Inc.

                16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.6.2. Financial Overview

                16.3.6.3. Product Portfolio

                16.3.6.4. Strategic Overview

                16.3.6.5. SWOT Analysis

            16.3.7. Charles River Laboratories, Inc.

                16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.7.2. Financial Overview

                16.3.7.3. Product Portfolio

                16.3.7.4. Strategic Overview

                16.3.7.5. SWOT Analysis

            16.3.8. Icon plc

                16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.8.2. Financial Overview

                16.3.8.3. Product Portfolio

                16.3.8.4. Strategic Overview

                16.3.8.5. SWOT Analysis

            16.3.9. WuXi AppTec Group

                16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.9.2. Financial Overview

                16.3.9.3. Product Portfolio

                16.3.9.4. Strategic Overview

                16.3.9.5. SWOT Analysis

            16.3.10. Medpace

                16.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

                16.3.10.2. Financial Overview

                16.3.10.3. Product Portfolio

                16.3.10.4. Strategic Overview

                16.3.10.5. SWOT Analysis

    List of Tables

    Table 01: CROs - Heat Map Analysis

    Table 02: CROs – Business Models

    Table 03: Global CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

    Table 04: Global CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

    Table 05: Global CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

    Table 06: Global CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

    Table 07: Global CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

    Table 08: Global CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

    Table 09: Global CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 10: Global CRO Services Market Value (US$ Mn) Forecast, by Region, 2017–2027

    Table 11: North America CRO Services Market Value (US$ Mn) Forecast, by Country, 2017–2027

    Table 12: North America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

    Table 13: North America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

    Table 14: North America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

    Table 15: North America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

    Table 16: North America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

    Table 17: North America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

    Table 18: North America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 19: Europe CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 20: Europe CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

    Table 21: Europe CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

    Table 22: Europe CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

    Table 23: Europe CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

    Table 24: Europe CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

    Table 25: Europe CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

    Table 26: Europe CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 27: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 28: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

    Table 29: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

    Table 30: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

    Table 31: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

    Table 32: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

    Table 33: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

    Table 34: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 35: Latin America CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 36: Latin America CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

    Table 37: Latin America CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

    Table 38: Latin America CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

    Table 39: Latin America CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

    Table 40: Latin America CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

    Table 41: Latin America CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

    Table 42: Latin America CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    Table 43: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

    Table 44: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Service Type, 2017–2027

    Table 45: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

    Table 46: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

    Table 47: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

    Table 48: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

    Table 49: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by Therapeutic Indication, 2017–2027

    Table 50: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, by End-user, 2017–2027

    List of Figures

    Figure 01: Global Contract Research Organization (CRO) Services Market Snapshot

    Figure 02: Global Contract Research Organization (CRO) Services Market Value (US$ Mn), by Region, 2019 and 2027

    Figure 03: Penetration of Clinical CRO Outsourcing Services

    Figure 04: Increase in Clinical Trials

    Figure 05: Global CRO Services Market Value (US$ Mn) Forecast, 2017–2027

    Figure 06: Global CRO Services Market Value Share (%), by Service Type (2019)

    Figure 07: Global CRO Services Market Value Share (%), by Therapeutic Indication (2019)

    Figure 08: Global CRO Services Market Value Share (%), by End-user (2019)

    Figure 09: Global CRO Services Market Value Share (%), by Region (2019)

    Figure 10: Regulatory Scenario – North America

    Figure 11: Regulatory Scenario – Europe

    Figure 12: Regulatory Scenario – Asia Pacific 

    Figure 13: Number of Registered Studies, by Location

    Figure 14: Number of Registered Studies, by Intervention

    Figure 15: Global CRO Services Market – Key Mergers and Acquisitions

    Figure 16: CROs- Pricing Strategies 

    Figure 17: Key Strategies – Laboratory Corporation of America Holdings (LabCorp) 

    Figure 18: Key Strategies – IQVIA 

    Figure 19: Global CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

    Figure 20: Global CRO Services Market Attractiveness, by Service Type, 2019?2027

    Figure 21: Global CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

    Figure 22: Global CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

    Figure 23: Global CRO Services Market Value Share Analysis, by Preclinical Services, 2018 and 2027

    Figure 24: Global CRO Services Market Attractiveness, by Preclinical Services, 2019?2027

    Figure 25: Global CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

    Figure 26: Global CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

    Figure 27: Global CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

    Figure 28: Global CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

    Figure 29: Global CRO Services Market Value (US$ Mn) Forecast, by Early Phase Development, 2017–2027

    Figure 30: Global CRO Services Market Value (US$ Mn) Forecast, by Clinical Research Services, 2017–2027

    Figure 31: Global CRO Services Market Value (US$ Mn) Forecast, by Laboratory Services, 2017–2027

    Figure 32: Global CRO Services Market Value (US$ Mn) Forecast, by Consulting Services, 2017–2027

    Figure 33: Global CRO Services Market Value (US$ Mn) Forecast, by Discovery Services, 2017–2027

    Figure 34: Global CRO Services Market Value (US$ Mn) Forecast, by Chemistry, 2017–2027

    Figure 35: Global CRO Services Market Value (US$ Mn) Forecast, by Preclinical Services, 2017–2027

    Figure 36: Global CRO Services Market Value (US$ Mn) Forecast, by Phase I, 2017–2027

    Figure 37: Global CRO Services Market Value (US$ Mn) Forecast, by Phase II, 2017–2027

    Figure 38: Global CRO Services Market Value (US$ Mn) Forecast, by Phase III, 2017–2027

    Figure 39: Global CRO Services Market Value (US$ Mn) Forecast, by Phase IV, 2017–2027

    Figure 40: Global CRO Services Market Value (US$ Mn) Forecast, by Bio-analytical services, 2017–2027

    Figure 41: Global CRO Services Market Value (US$ Mn) Forecast, by Analytical Services, 2017–2027

    Figure 42: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027

    Figure 43: Global CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

    Figure 44: Global CRO Services Market Value (US$ Mn) Forecast, by Oncology, 2017–2027

    Figure 45: Global CRO Services Market Value (US$ Mn) Forecast, by Infectious Diseases, 2017–2027

    Figure 46: Global CRO Services Market Value (US$ Mn) Forecast, by Immunological Disorders, 2017–2027

    Figure 47: Global CRO Services Market Value (US$ Mn) Forecast, by Respiratory Diseases, 2017–2027

    Figure 48: Global CRO Services Market Value (US$ Mn) Forecast, by Cardiovascular Diseases, 2017–2027

    Figure 49: Global CRO Services Market Value (US$ Mn) Forecast, by Neurological Disorders, 2017–2027

    Figure 50: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027

    Figure 51: Global CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

    Figure 52: Global CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 53: Global CRO Services Market Value (US$ Mn) Forecast, by Medical Device Companies , 2017–2027

    Figure 54: Global CRO Services Market Value (US$ Mn) Forecast, by Biopharmaceutical Companies, 2017–2027

    Figure 55: Global CRO Services Market Value (US$ Mn) Forecast, by Others, 2017–2027

    Figure 56: Global CRO Services Market Attractiveness, by End-user, 2019?2027

    Figure 57: Global CRO Services Market: Regional Outlook

    Figure 58: Global CRO Services Market Value (US$ Mn) Forecast, 2017–2027

    Figure 59: Global CRO Services Market Value Share Analysis, by Region, 2018 and 2027

    Figure 60: Global CRO Services Market Attractiveness, by Region, 2019?2027

    Figure 61: North America CRO Services Market Value (US$ Mn) Forecast, 2017–2027

    Figure 62: North America CRO Services Market Attractiveness Analysis, by Country, 2019–2027

    Figure 63: North America CRO Services Market Value Share Analysis, by Country, 2018 and 2027

    Figure 64: North America CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

    Figure 65: North America CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

    Figure 66: North America CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

    Figure 67: North America CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

    Figure 68: North America CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

    Figure 69: North America CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 70: North America CRO Services Market Attractiveness, by Service Type, 2019?2027

    Figure 71: North America CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

    Figure 72: North America CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

    Figure 73: North America CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

    Figure 74: North America CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

    Figure 75: North America CRO Services Market Attractiveness, by End-user, 2019?2027

    Figure 76: Europe CRO Services Market Value (US$ Mn) Forecast, 2017–2027

    Figure 77: Europe CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 78: Europe CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 79: Europe CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

    Figure 80: Europe CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

    Figure 81: Europe CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

    Figure 82: Europe CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

    Figure 83: Europe CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

    Figure 84: Europe CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 85: Europe CRO Services Market Attractiveness, by Service Type, 2019?2027

    Figure 86: Europe CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

    Figure 87: Europe CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

    Figure 88: Europe CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

    Figure 89: Europe CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

    Figure 90: Europe CRO Services Market Attractiveness, by End-user, 2019?2027

    Figure 91: Asia Pacific CRO Services Market Value (US$ Mn) Forecast, 2017–2027

    Figure 92: Asia Pacific CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 93: Asia Pacific CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 94: Asia Pacific CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

    Figure 95: Asia Pacific CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

    Figure 96: Asia Pacific CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

    Figure 97: Asia Pacific CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

    Figure 98: Asia Pacific CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

    Figure 99: Asia Pacific CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 100: Asia Pacific CRO Services Market Attractiveness, by Service Type, 2019?2027

    Figure 101: Asia Pacific CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

    Figure 102: Asia Pacific CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

    Figure 103: Asia Pacific CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

    Figure 104: Asia Pacific CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

    Figure 105: Asia Pacific CRO Services Market Attractiveness, by End-user, 2019?2027

    Figure 106: Latin America CRO Services Market Value (US$ Mn) Forecast, 2017–2027

    Figure 107: Latin America CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 108: Latin America CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 109: Latin America CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

    Figure 110: Latin America CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

    Figure 111: Latin America CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

    Figure 112: Latin America CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

    Figure 113: Latin America CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

    Figure 114: Latin America CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 115: Latin America CRO Services Market Attractiveness, by Service Type, 2019?2027

    Figure 116: Latin America CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

    Figure 117: Latin America CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

    Figure 118: Latin America CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

    Figure 119: Latin America CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

    Figure 120: Latin America CRO Services Market Attractiveness, by End-user, 2019?2027

    Figure 121: Middle East & Africa CRO Services Market Value (US$ Mn) Forecast, 2017–2027

    Figure 122: Middle East & Africa CRO Services Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

    Figure 123: Middle East & Africa CRO Services Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

    Figure 124: Middle East & Africa CRO Services Market Value Share Analysis, by Service Type, 2018 and 2027

    Figure 125: Middle East & Africa CRO Services Market Value Share Analysis, by Early Phase Development, 2018 and 2027

    Figure 126: Middle East & Africa CRO Services Market Value Share Analysis, by Clinical Research Services, 2018 and 2027

    Figure 127: Middle East & Africa CRO Services Market Value Share Analysis, by Laboratory Services, 2018 and 2027

    Figure 128: Middle East & Africa CRO Services Market Value Share Analysis, by Therapeutic Indication, 2018 and 2027

    Figure 129: Middle East & Africa CRO Services Market Value Share Analysis, by End-user, 2018 and 2027

    Figure 130: Middle East & Africa CRO Services Market Attractiveness, by Service Type, 2019?2027

    Figure 131: Middle East & Africa CRO Services Market Attractiveness, by Early Phase Development, 2019?2027

    Figure 132: Middle East & Africa CRO Services Market Attractiveness, by Clinical Research Services, 2019?2027

    Figure 133: Middle East & Africa CRO Services Market Attractiveness, by Laboratory Services, 2019?2027

    Figure 134: Middle East & Africa CRO Services Market Attractiveness, by Therapeutic Indication, 2019?2027

    Figure 135: Middle East & Africa CRO Services Market Attractiveness, by End-user, 2019?2027

    Figure 136: Global CRO Services Market Share, by Company, 2018

Copyright © Transparency Market Research, Inc. All Rights reserved